metoclopramide has been researched along with Adenocarcinoma in 11 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Radiation induced cytotoxicity was potentiated by neutralized metoclopramide (nMCA; Neu-Sensamide, Oxigene Inc) when a human lung adenocarcinoma (H2981) transplanted into scid mice and an adeno-type 12 virus induced mouse sarcoma (A12B3) inoculated into CBA mice were exposed in vivo to low dose radiation at single doses of 1 and 2 Gy respectively." | 7.69 | Neutral metoclopramide induces tumor cytotoxicity and sensitizes ionizing radiation of a human lung adenocarcinoma and virus induced sarcoma in mice. ( Hua, J; Olsson, AR; Pero, RW; Sheng, Y, 1997) |
| " The syndrome was associated with metoclopramide antiemetic therapy given for post-operative nausea and vomiting." | 7.68 | Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy. ( Bakri, YN; Kawi, Z; Khan, R; Subhi, J, 1992) |
| "Crizotinib is an orally active multi-target tyrosine kinase inhibitor which is the standard of care in patients with anaplastic lymphoma kinase translocated non-small-cell lung cancer." | 5.42 | When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs. ( Aieta, M; Gallucci, G; Lombardi, L; Tartarone, A, 2015) |
| "Radiation induced cytotoxicity was potentiated by neutralized metoclopramide (nMCA; Neu-Sensamide, Oxigene Inc) when a human lung adenocarcinoma (H2981) transplanted into scid mice and an adeno-type 12 virus induced mouse sarcoma (A12B3) inoculated into CBA mice were exposed in vivo to low dose radiation at single doses of 1 and 2 Gy respectively." | 3.69 | Neutral metoclopramide induces tumor cytotoxicity and sensitizes ionizing radiation of a human lung adenocarcinoma and virus induced sarcoma in mice. ( Hua, J; Olsson, AR; Pero, RW; Sheng, Y, 1997) |
| " The syndrome was associated with metoclopramide antiemetic therapy given for post-operative nausea and vomiting." | 3.68 | Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy. ( Bakri, YN; Kawi, Z; Khan, R; Subhi, J, 1992) |
| "Heptaplatin is a newly developed platinum derivative which has been reported to be less toxic than cisplatin." | 2.70 | Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer. ( Ahn, JH; Bahng, H; Chang, HM; Kang, WC; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, JS, 2002) |
| "Crizotinib is an orally active multi-target tyrosine kinase inhibitor which is the standard of care in patients with anaplastic lymphoma kinase translocated non-small-cell lung cancer." | 1.42 | When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs. ( Aieta, M; Gallucci, G; Lombardi, L; Tartarone, A, 2015) |
| "Twenty-two advanced consecutive thyroid cancer patients with varying histologies were treated with the so called BAP regime which consisted of bleomycin (B) 30 mg a day for three days, adriamycin (A) 60 mg/m2 iv in day 5, and cisplatinum (P) 60 to mg/m2 iv in day 5." | 1.28 | Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. ( Busnardo, B; Casara, D; De Besi, P; Fiorentino, MV; Girelli, ME; Nacamulli, D; Simioni, N; Toso, S; Zorat, P, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallucci, G | 1 |
| Tartarone, A | 1 |
| Lombardi, L | 1 |
| Aieta, M | 1 |
| Arroyo-Cózar, M | 1 |
| Grau Delgado, J | 1 |
| Gabaldón Conejos, T | 1 |
| Ahn, JH | 1 |
| Kang, YK | 1 |
| Kim, TW | 1 |
| Bahng, H | 1 |
| Chang, HM | 1 |
| Kang, WC | 1 |
| Kim, WK | 1 |
| Lee, JS | 1 |
| Park, JS | 1 |
| Farthmann, EH | 1 |
| Fritsch, WP | 1 |
| Davies, PG | 1 |
| Hua, J | 2 |
| Olsson, A | 1 |
| Sheng, Y | 2 |
| Pero, RW | 2 |
| Olsson, AR | 1 |
| Bakri, YN | 1 |
| Khan, R | 1 |
| Subhi, J | 1 |
| Kawi, Z | 1 |
| De Besi, P | 1 |
| Busnardo, B | 1 |
| Toso, S | 1 |
| Girelli, ME | 1 |
| Nacamulli, D | 1 |
| Simioni, N | 1 |
| Casara, D | 1 |
| Zorat, P | 1 |
| Fiorentino, MV | 1 |
| Vaughn, CB | 1 |
| Chapman, JL | 1 |
| Herschman, BR | 1 |
| Bonczak, MJ | 1 |
| Treisman, EJ | 1 |
| Groshko, GA | 1 |
| Nirenberg, PL | 1 |
| Markman, M | 1 |
| Newman, DR | 1 |
| Hawkins, RS | 1 |
1 trial available for metoclopramide and Adenocarcinoma
| Article | Year |
|---|---|
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protoc | 2002 |
10 other studies available for metoclopramide and Adenocarcinoma
| Article | Year |
|---|---|
When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Bradycardia; | 2015 |
Hiccups induced by midazolam during sedation in flexible bronchoscopy.
Topics: Adenocarcinoma; Bronchoscopy; Conscious Sedation; Female; Flumazenil; GABA Modulators; Hiccup; Human | 2012 |
[Conditions after total gastrectomy].
Topics: Adenocarcinoma; Anemia, Hypochromic; Antacids; Cholestyramine Resin; Dumping Syndrome; Esophagitis, | 1982 |
Spontaneous resolution of adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Humans; Metoclopramide; Spironolactone; Stomach Neoplasms | 1984 |
Acidic and neutralized metoclopramide formulations sensitize ionizing radiation induced cytotoxicity in a human lung adenocarcinoma xenografted to scid mice.
Topics: Adenocarcinoma; Animals; Female; Humans; Lung Neoplasms; Male; Metoclopramide; Mice; Mice, SCID; Neo | 1995 |
Neutral metoclopramide induces tumor cytotoxicity and sensitizes ionizing radiation of a human lung adenocarcinoma and virus induced sarcoma in mice.
Topics: Adenocarcinoma; Animals; Apoptosis; Dose-Response Relationship, Radiation; Female; Humans; Lung Neop | 1997 |
Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy.
Topics: Adenocarcinoma; Antiemetics; Female; Humans; Metoclopramide; Middle Aged; Nausea; Neuroleptic Malign | 1992 |
Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.
Topics: Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethas | 1991 |
Intraperitoneal and systemic chemotherapy for advanced endometrial adenocarcinoma: a case report.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplati | 1990 |
Parkinsonism following i.v. administration of high-dose metoclopramide used as an antiemetic agent during cancer chemotherapy.
Topics: Abdominal Neoplasms; Adenocarcinoma; Aged; Cisplatin; Female; Humans; Metoclopramide; Nausea; Ovaria | 1985 |